<DOC>
	<DOCNO>NCT00158132</DOCNO>
	<brief_summary>Cocaine addiction serious health problem available medical treatment prevent relapse . Amantadine , medication improves muscle control , propranolol , medication lower blood pressure , may useful treat cocaine addiction individual severe cocaine withdrawal symptom . This study evaluate effectiveness amantadine propranolol prevent drug relapse among cocaine addict .</brief_summary>
	<brief_title>Effectiveness Amantadine Propranolol Treating Cocaine Dependence - 2</brief_title>
	<detailed_description>Cocaine withdrawal symptom major contribute factor outpatient cocaine dependence treatment program often fail . Individuals severe cocaine withdrawal symptom often experience anxiety , shake , muscle pain . Amantadine medication currently use improve muscle control , reduce shake , lessen stiffness . Therefore , may help reduce muscle pain cocaine addict experience . By enhance activity brain chemical dopamine , amantadine may also reduce symptom associate cocaine withdrawal . Propranolol medication currently use treat high blood pressure irregular heart rhythm . It may reduce anxiety lessen cocaine craving individual addict cocaine . The purpose study evaluate effectiveness amantadine propranolol , alone combination , treat cocaine addict severe cocaine withdrawal symptom . A 2-week baseline evaluation period follow 8-week treatment phase . During baseline evaluation , cocaine use measure urine test , three time week . Only participants experience severe withdrawal symptom use cocaine least twice first 2 week continue study . Eligible individual randomly assign receive amantadine alone , propranolol alone , combination amantadine propranolol , placebo . Treatments begin Week 3 study visit occur three time week . Cocaine level monitor throughout study urine test .</detailed_description>
	<mesh_term>Cocaine-Related Disorders</mesh_term>
	<mesh_term>Amantadine</mesh_term>
	<mesh_term>Cocaine</mesh_term>
	<mesh_term>Propranolol</mesh_term>
	<criteria>Male female , 18 60 year old . Meets DSMIV diagnosis criterion cocaine dependence determine Structured Clinical Interview DSMIV ( SCID ) Score least ( &gt; = ) 22 Initial Cocaine Selective Severity Assessment ( CSSA ) Lives within commute distance Treatment Research Center ( TRC ) Penn/VA Center Studies Addiction , University Pennsylvania If female , willing use contraception throughout study Continued use cocaine two week evaluation phase prior medication treatment demonstrate least 2 new us cocaine document quantitative urine toxicology screen obtain three time weekly accord new use rule Meets DSMIV/SCID diagnosis criterion dependence drug cocaine , marijuana , nicotine . Cocaine dependent subject identify cocaine dependence primary addiction also meet criterion alcohol dependence accept long alcohol dependence severe enough require medication alcohol detoxification . Concomitant treatment psychotropic medication . Patients mandate treatment base upon legal decision condition employment . This assessed patient 's selfreport . Current severe psychiatric symptom ( e.g. , psychosis , dementia , suicidal homicidal ideation , mania depression require antidepressant medication ) Sensitivity propranolol amantadine Use investigational medication within past 30 day . History significant heart disease ( arrhythmia require medication , WolffParkinson White Syndrome , angina pectoris , document history myocardial infarction , heart failure ) . History chest pain associated cocaine use prompt visit physician . Current use reserpine , verapamil , theophylline , trimethoprim , cimetidine , haloperidol , benzodiazepine , anticonvulsant Bronchospastic disease Hyperthyroidism Diabetes mellitus Patients known AIDS serious illness may require hospitalization study . Female subject pregnant lactating , female subject child bear potential use acceptable method birth control . Acceptable method birth control include : 1. barrier ( diaphragm condom ) spermicide 2. intrauterine progesterone contraceptive system 3. levonorgestrel implant 4. medroxyprogesterone acetate contraceptive injection 5. oral contraceptive . Patients impaired renal function indicate corrected creatinine clearance 80 ml/min/70 kg determine modify Cockcroft equation ( CDC , 1986 ) . Clinical laboratory test ( CBC , blood chemistry , urinalysis ) outside normal limit clinically unacceptable Principal Investigator . EKG 1st degree heart block , sinus tachycardia , leave axis deviation , nonspecific ST T wave change allow ; liver function test [ LFTs ] &lt; 5 x ULN acceptable ) . A complete list exclusionary lab result include appendix 1</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>cocaine</keyword>
</DOC>